Emicizumab in Patients With Acquired Hemophilia A
Condition(s):Acquired Hemophilia ALast Updated:February 26, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Acquired Hemophilia ALast Updated:February 26, 2024Recruiting
Condition(s):Hemophilia A; Hemophilia B; Factor VIII Deficiency; Factor IX DeficiencyLast Updated:December 14, 2016Completed
Condition(s):Hemophilia ALast Updated:April 6, 2023Recruiting
Condition(s):HemophiliaLast Updated:May 18, 2020Completed
Condition(s):HaemophiliaLast Updated:June 20, 2012Unknown status
Condition(s):HemophiliaLast Updated:November 13, 2023Completed
Condition(s):HemophiliaLast Updated:April 24, 2023Active, not recruiting
Condition(s):Hemophilia BLast Updated:January 6, 2022Completed
Condition(s):HemophiliaLast Updated:January 5, 2024Not yet recruiting
Condition(s):Haemophilia A; Haemophilia A With InhibitorsLast Updated:March 26, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.